Editas Medicine is a gene editing company based in the United States that develops treatments for serious diseases by modifying genes inside patients' cells. It works with CRISPR-based editing technologies and develops medicines aimed at inherited blood disorders and inherited forms of blindness, among other conditions. Its customers and partners are mainly hospitals, clinicians and research collaborators involved in clinical studies of these experimental therapies.
Editas Medicine, Inc. trades under the code 0IFK on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3272 of 3787 on the London Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
38/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-11.5%
From 52-week high-37.1%
MomentumWeak
18/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-13.4%
6-month return-25.5%
Stability (higher is calmer)Weak
21/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)82.7%
Worst drawdown, 1 year (smaller is calmer)-39.1%
LiquidityWeak
24/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.05M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 1.671 – 3.940Daily closes, split-adjusted
Signals
50-day average2.790
200-day average2.673
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.188
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 11 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 6 bearish
Monthly
Strongly bearish
0 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
2.47
Bearish
EMA 10
2.50
Bearish
SMA 20
2.58
Bearish
EMA 20
2.57
Bearish
SMA 50
2.79
Bearish
EMA 50
2.71
Bearish
SMA 100
2.84
Bearish
EMA 100
2.76
Bearish
SMA 200
2.67
Bearish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
41.60
Neutral
MACD (12, 26)
-0.10
Bearish
Momentum (12)
-14.16
Bearish
Stochastic %K (14)
15.33
Bullish
Williams %R (14)
-84.67
Bullish
CCI (20)
-100.2
Bullish
Pivot points (classic, last session)
S3
2.08
S2
2.19
S1
2.28
Pivot
2.39
R1
2.48
R2
2.59
R3
2.68
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
